Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Is there a role for radiotherapy in localized diffuse lymphomas?

  • 14 Accesses

  • 14 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Anderson T, Bender RA, Fisher RI, DeVita VT, Chabner BA, Berard CA, Norton L, Young RC (1977) Combination chemotherapy in non-Hodgkin's lymphoma: Results of long-term follow up. Cancer Treat Rep 61:1057

  2. 2.

    Bitran JD, Kinzie J, Sweet DL, Variakojis D, Griem ML, Golomb HM, Miller JB, Oetzel N, Ultmann JE (1977) Survival of patients with localized histiocytic lymphoma. Cancer 39:342

  3. 3.

    Bonadonna G, Lattuada A, Monfardini S, Milani F, Banfi A (1979) Combined radiotherapy-chemotherapy in localized non-Hodgkin's lymphomas: 5-year results of a randomized study. In: Salmon WE, Jones SE (eds) Adjuvant therapy of cancer II. Grune & Stratton, New York, p 145

  4. 4.

    Cabanillas F, Bodey GP, Freireich EJ (1979) Chemotherapy alone for management of Stage I and II malignant lymphoma of unfavorable histology. Proc AACR ASCO 20:19

  5. 5.

    Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB (1979) Results of radiotherapy in control of Stage I and II non-Hodgkin's lymphoma. Cancer 43:1245

  6. 6.

    Fuks Z, Kaplan HS (1973) Recurrence rates following therapy of nodular and diffuse malignant lymphomas. Radiology 108:675

  7. 7.

    Glatstein E, Fuks Z, Goffinet DR, Kaplan HS (1976) Non-Hodgkin's lymphomas of Stage III extent. Is total lymphoid irridiation appropriate treatment? Cancer 37:2806

  8. 8.

    Glatstein E, Portlock C, Rosenberg SA, Kaplan HS (1977) Combined modality treatment in the malignant lymphomas. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. North-Holland, New York, p 545

  9. 9.

    Goffinet DR, Warnke R, Dunnick NR, Castellino R, Glatstein E, Nelsen TS, Dorfman RF, Rosenberg SA, Kaplan HS (1977) Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep 61:981

  10. 10.

    Jones SE (1975) Non-Hodgkin's lymphomas. JAMA 234:633

  11. 11.

    Jones SE, Fuks Z, Kaplan HS, Rosenberg SA (1973) Non-Hodgkin's lymphomas V. Results of radiotherapy. Cancer 32:682

  12. 12.

    Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H (1973) Non-Hodgkin's lymphoma's IV. Clinico-pathologic correlation in 405 cases. Cancer 31:806

  13. 13.

    Jones SE, Grozea PN, Metz EN, Haut A, Stevens RL, Morrison FS, Butler JJ, Byrne GE, Moon TE, Fischer R, Haskins CL, Coltman CA (1979) Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma. A southwest oncology group study. Cancer 43:417

  14. 14.

    Kushlan P, Coleman CN, Glatstein EJ, Rosenberg SA, Kaplan HS (1978) Prognostic factors in Stage II diffuse histiocytic lymphoma. Proc AACR ASCO 19:337

  15. 15.

    Landberg TG, Häkansson LG, Möller TR, Mattsson WKI, Landys KE, Johansson BG, Killander DCF, Molin BF, Westling PF, Lenner PH, Dahl OG (1979) CVP-remission-maintenance in Stage I or II non-Hodgkin's lymphomas. Preliminary results of a randomized study. Cancer 44:831

  16. 16.

    Levitt SH, Bloomfield CD, Frizzera G, Lee CKK (1980) Curative radiotherapy for localized diffuse histiocytic lymphoma. Cancer Treat Rep (in press)

  17. 17.

    McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Gulterman J, Coltman C, Moon TE (1976) Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484

  18. 18.

    Miller TP, Jones SE (1979) Chemotherapy of localised histiocytic lymphoma. Lancet 1:358

  19. 19.

    Nathwani BN (1979) A critical analysis of the classifications of non-Hodgkin's lymphomas. Cancer 44:347

  20. 20.

    Osborne CK, Merrill JM, Garvin AS, DeVita VT, Young RC (1979) Nodular histiocytic lymphoma. An aggressive nodular lymphoma with potential for long term survival. Proc AACR ASCO 20:442

  21. 21.

    Portlock CS, Rosenberg SA (1979) No initial therapy for Stage III and IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med 90:10

  22. 22.

    Rodriguez V, Cabanillas F, Burgess MA, McKelvey EM, Valdivieso M, Bodey GP, Freireich EJ (1977) combination chemotherapy (“Chop-Bleo”) in advanced (non-Hodgkin's) malignant lymphoma. Blood 49:325

  23. 23.

    Schein PS, DeVita VT, Hubbard S, Chabner BS, Canellos GP, Berard C, Young RC (1976) Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 85:417

Download references

Author information

Correspondence to S. E. Jones.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Miller, T.P., Jones, S.E. Is there a role for radiotherapy in localized diffuse lymphomas?. Cancer Chemother. Pharmacol. 4, 67–70 (1980). https://doi.org/10.1007/BF00254024

Download citation